News

Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States.  In 2012, Congress passed legislation making it a...

Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99). The supply...

nuclear imaging, isotopes, Molybdenum-99

Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States. 

September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered into an agreement with GE Healthcare in...

NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Co., marking further progress toward establishing the first existing...

July 22, 2014 — NorthStar Medical Radioisotopes broke ground on a new 50,000-square-foot facility in Beloit, Wis. When completed in late 2014, the facility will house the company’s...

July 8, 2014 — NorthStar Medical Radioisotopes LLC has signed a pledge with the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO), designed to help the...

Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, Coquí RadioPharmaceuticals Corp. is he only one using a design and...

Symbia, Intevo, SPECT/CT, Siemens

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT)....

An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer ...

ultraspect xpress.cardiac nuclear imaging spect radiation dose

As the global medical isotope shortage continues indefinitely following the plant leak in South Africa, Berks Cardiologists Ltd., a cardiovascular imaging center in central Pennsylvania, is...

radiopharmaceuticals and tracers nuclear molecular imaging FDA lexiscan

The U.S. Food and Drug Administration (FDA) is warning healthcare professionals of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test agents Lexiscan (...

rsna 2013 radiopharmaceuticals tracers nuclear imaging trial study flurpiridaz

Lantheus Medical Imaging, Inc., a developer, manufacturer and distributor of diagnostic imaging agents,...

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission...

Positron Corporation entered into a multi-year radioisotope supply agreement with iThemba LABS of Cape Town, South Africa. The supply agreement contracts the procurement of raw material, strontium...

PET vs SPECT, flurpiridaz

Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT). Nevertheless, widespread clinical...

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both...

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems

Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete...

Cardiolite vials

Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license and distribute Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for...

Chalk River Labs

Atomic Energy of Canada Limited (AECL) will commence a 30-day planned shutdown for inspection and maintenance of the National Research Universal (NRU) reactor at Chalk River, Ontario, starting...